Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Mercier

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Nature Communications|January 12, 2021
Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AMLToshihiko Oki, Francois Mercier, Hiroki Kato, et al.
Investigational New Drugs|August 21, 2021
In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK)Georgina Meneses-Lorente, Stephen Fowler, Elena Guerini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150René Bruno, Mathilde Marchand, Kenta Yoshida, et al.
Blood Advances|July 14, 2023
The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progressionYoumna S Kfoury, Fei Ji, Esha Jain, et al.
The Lancet. Neurology|June 15, 2013
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 studyKrzysztof Selmaj, David K B Li, Hans-Peter Hartung, et al.
Molecular Cancer Therapeutics|October 22, 2020
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral ActivityJamilah Abusarah, Yun Cui, Nehme El-Hachem, et al.
Clinical Pharmacology and Therapeutics|June 23, 2020
Opportunities for Quantitative Translational Modeling in OncologyJames W T Yates, Helen Byrne, Sonya C Chapman, et al.
Cell|May 28, 2019
A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and LeukemiaNinib Baryawno, Dariusz Przybylski, Monika S Kowalczyk, et al.
Cell Stem Cell|September 22, 2021
tiRNA signaling via stress-regulated vesicle transfer in the hematopoietic nicheYoumna S Kfoury, Fei Ji, Michael Mazzola, et al.
Cell|September 3, 2011
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemiasStephen M Sykes, Steven W Lane, Lars Bullinger, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nature Communications|January 12, 2021
Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AMLToshihiko Oki, Francois Mercier, Hiroki Kato, et al.
Investigational New Drugs|August 21, 2021
In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK)Georgina Meneses-Lorente, Stephen Fowler, Elena Guerini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150René Bruno, Mathilde Marchand, Kenta Yoshida, et al.
Blood Advances|July 14, 2023
The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progressionYoumna S Kfoury, Fei Ji, Esha Jain, et al.
The Lancet. Neurology|June 15, 2013
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 studyKrzysztof Selmaj, David K B Li, Hans-Peter Hartung, et al.
Molecular Cancer Therapeutics|October 22, 2020
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral ActivityJamilah Abusarah, Yun Cui, Nehme El-Hachem, et al.
Clinical Pharmacology and Therapeutics|June 23, 2020
Opportunities for Quantitative Translational Modeling in OncologyJames W T Yates, Helen Byrne, Sonya C Chapman, et al.
Cell|May 28, 2019
A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and LeukemiaNinib Baryawno, Dariusz Przybylski, Monika S Kowalczyk, et al.
Cell Stem Cell|September 22, 2021
tiRNA signaling via stress-regulated vesicle transfer in the hematopoietic nicheYoumna S Kfoury, Fei Ji, Michael Mazzola, et al.
Cell|September 3, 2011
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemiasStephen M Sykes, Steven W Lane, Lars Bullinger, et al.
Pageof 5